Nasus Pharma Ltd. (NSRX)
NYSEAMERICAN: NSRX · Real-Time Price · USD
4.110
-0.750 (-15.43%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Nasus Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 48 | - | - | - |
| Enterprise Value | 51 | - | - | - |
| Debt / Equity Ratio | -0.59 | -0.56 | -0.65 | -0.56 |
| Net Debt / Equity Ratio | -0.55 | -0.47 | -0.60 | -0.51 |
| Quick Ratio | 0.04 | 0.10 | 0.05 | 0.05 |
| Current Ratio | 0.06 | 0.12 | 0.11 | 0.13 |
| Return on Assets (ROA) | -106.39% | -116.06% | -166.52% | - |
| Return on Capital Employed (ROCE) | 32.70% | 33.60% | 30.20% | 73.30% |
| Buyback Yield / Dilution | -5.44% | 0.43% | -2.44% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.